[Anatomical Lung Resection Following Neoadjuvant Chemoimmunotherapy: Technical Aspects and Case Reports]. / Anatomische Lungenresektion nach neoadjuvanter Chemo-Immuntherapie: technische Aspekte und klinische Fallbeispiele.
Zentralbl Chir
; 149(S 01): S26-S34, 2024 Aug.
Article
em De
| MEDLINE
| ID: mdl-39137759
ABSTRACT
Since the approval of neoadjuvant chemo-immunotherapy in Europe, treatment options for resectable stage II-III NSCLC have also significantly improved in clinical routine. Surgical excision of the tumour by anatomic lung resection still remains the most essential component of multimodal therapy. However, with the increasing use of the new treatment concepts in clinical routine, questions also arise regarding safety, adverse events and technical resectability following neoadjuvant chemo-immunotherapy. This review summarises the current data on perioperative safety following neoadjuvant chemo-immunotherapy and discusses aspects of surgical technique, the extent of resection and intraoperative challenges illustrated by clinical case reports.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumonectomia
/
Carcinoma Pulmonar de Células não Pequenas
/
Terapia Neoadjuvante
/
Neoplasias Pulmonares
/
Estadiamento de Neoplasias
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
De
Ano de publicação:
2024
Tipo de documento:
Article